←Back to Expert Scholars
Translational Medicine / 转化医学Cutaneous T-Cell Lymphoma
Steven Horwitz
MD
🏢Memorial Sloan Kettering Cancer Center🌐USA
Attending Physician, Lymphoma Service
72
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Steven Horwitz led the ALCANZA trial establishing brentuximab vedotin in CD30-positive CTCL. His work spans systemic T-cell lymphoma clinical development. He has shaped international treatment standards for advanced CTCL.
Share:
🧪Research Fields 研究领域
T-cell lymphoma
Brentuximab vedotin
CTCL systemic therapy
Clinical trials
Lymphoma biology
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Steven Horwitz 的研究动态
Follow Steven Horwitz's research updates
留下邮箱，当我们发布与 Steven Horwitz（Memorial Sloan Kettering Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment